Tumour-fraction limit of detection in in silico mixtures (DecoNFlow benchmark, Giuili et al. 2025)
Proxy evidenceIndependent study: Reported in a study whose authors did not develop the evaluated tool.Limit of detection (lower is better), with the other metrics below each value. The best value in each column is highlighted.
| Tool | WGBS-TT | RRBS-TT | RRBS-CL |
|---|---|---|---|
| 0.0085 (best in column)median at 183M aligned reads | 0.0100median at 10M aligned reads | 0.0030median at 10M aligned reads | |
| 0.0100median at 183M aligned reads | 0.0070* (best in column)median at 10M aligned reads | 0.0010 (best in column)median at 10M aligned reads | |
| 0.0100median at 183M aligned reads | 0.0100median at 10M aligned reads | Not reported | |
MetDecodespecialist model | 0.0250median at 183M aligned reads | 0.0250median at 10M aligned reads | Not reported |
UXMconventional | 0.0250median at 183M aligned reads | 0.1000median at 10M aligned reads | Not reported |
PRMethspecialist model | 0.0500median at 183M aligned reads | 0.0250median at 10M aligned reads | Not reported |
CIBERSORTspecialist model | 0.1750median at 183M aligned reads | 0.0500median at 10M aligned reads | Not reported |
EpiDISH_RPCconventional | 0.1750median at 183M aligned reads | 0.0500median at 10M aligned reads | 0.1000median at 10M aligned reads |
EpiSCOREspecialist model | 0.1750median at 183M aligned reads | 0.0500median at 10M aligned reads | 0.0500median at 10M aligned reads |
Caveats and method
What each column measures:
- WGBS-TT: Median tumour-fraction limit of detection of ten reference-based deconvolution tools on WGBS-TT mixtures, by sequencing depth and overall
- RRBS-TT: Median tumour-fraction limit of detection of ten reference-based deconvolution tools on RRBS-TT mixtures, by sequencing depth and overall
- RRBS-CL: Median tumour-fraction limit of detection of five reference-based deconvolution tools (of ten benchmarked) on RRBS-CL mixtures, by sequencing depth and overall
- In silico mixtures of tumour tissue or cell-line reads into healthy plasma reads, not patient plasma
- Medians on a discrete grid of tested fractions
- Preprint, not peer reviewed
- This dataset's values in Supplementary Table 3 agree with Figure 4A; the RRBS-CL block of the same table has a conflict that does not affect them.
- Each median pools tumour types and the three DMR selection tools; the table does not list the pooled combinations. The two reference-free tools of the benchmark are not in Supplementary Table 3.
- UXM, MetDecode, meth_atlas, PRMeth and CIBERSORT are excluded: their RRBS-CL values conflict between Supplementary Table 3 sheet A, sheet B and Figure 4A. The five tools shown agree across all three.
- One neuroblastoma cell line (CLB-GA) mixed into healthy plasma reads; the reference holds nine other neuroblastoma cell lines.
Protocols: DecoNFlow WGBS-TT tumour-fraction limit of detection, DecoNFlow RRBS-TT tumour-fraction limit of detection, DecoNFlow RRBS-CL tumour-fraction limit of detection